Keyphrases
Prostate-specific Antigen
100%
Flutamide
100%
Finasteride
100%
Primary Therapy
100%
Recurrent Prostate Cancer
100%
Prostate-specific Antigen Level
50%
Twice Daily
33%
Definitive Therapy
33%
Computed Tomography
16%
Abdomen
16%
Pelvis
16%
Metastasis
16%
Start of Treatment
16%
Prostate Cancer
16%
Response to Therapy
16%
Tolerability
16%
Initial Treatment
16%
Lost to Follow-up
16%
Radionuclide Bone Scan
16%
Total Prostate-specific Antigen
16%
External Beam Radiotherapy
16%
Disease Status
16%
Recurrence-free Survival
16%
Radical Retropubic Prostatectomy
16%
Recurrence Prediction
16%
Disease Response
16%
Gynecomastia
16%
Protocol Compliance
16%
Biochemical Recurrence
16%
Gastrointestinal Disturbances
16%
Breast Tenderness
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Prostate Specific Antigen
100%
Finasteride
100%
Flutamide
100%
Side Effect
30%
Recurrent Disease
20%
Radioisotope
10%
Tolerability
10%
Recurrence Free Survival
10%
Gastrointestinal Symptom
10%
Gynecomastia
10%
Diseases
10%
Biochemical Recurrence
10%
Libido Disorder
10%